Nathalie Barbier Selected Research

Tetanus

2/2005

Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathalie Barbier Research Topics

Disease

7	Atopic Dermatitis (Atopic Eczema) 05/2008 - 08/2002
2	Asthma (Bronchial Asthma) 01/2021 - 01/2011
2	Pruritus (Itching) 01/2014 - 08/2002
2	Inflammation (Inflammations) 01/2012 - 01/2011
2	Eczema 05/2008 - 01/2005
1	Urticaria (Hives) 02/2022
1	Chronic Urticaria 02/2022
1	Allergic Rhinitis 01/2014
1	Hypersensitivity (Allergy) 06/2013
1	Anaphylaxis (Anaphylactic Shock) 06/2013
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 01/2006
1	Infections 01/2006
1	Tetanus 02/2005
1	Measles 02/2005
1	Rubella (German Measles) 02/2005
1	Diphtheria 02/2005
1	Necrosis 12/2004

Drug/Important Bio-Agent (IBA)

7	pimecrolimus (Elidel)FDA Link 05/2008 - 08/2002
3	CytokinesIBA 01/2005 - 08/2002
2	Interleukin-10 (Interleukin 10)IBA 01/2014 - 01/2011
2	AllergensIBA 01/2014 - 01/2011
2	Pharmaceutical PreparationsIBA 12/2004 - 08/2002
1	ligelizumabIBA 02/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2021
1	indacaterolIBA 01/2021
1	IridiumIBA 01/2021
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2021
1	Salmeterol Xinafoate (Serevent)FDA Link 01/2021
1	PowdersIBA 01/2014
1	Interleukin-5 (Interleukin 5)IBA 01/2014
1	Interleukin-13IBA 01/2014
1	Peptides (Polypeptides)IBA 06/2013
1	Immunoglobulin E (IgE)IBA 06/2013
1	OvalbuminIBA 01/2011
1	AerosolsIBA 01/2011
1	Therapeutic UsesIBA 01/2011
1	Calcineurin InhibitorsIBA 01/2006
1	AntibodiesIBA 02/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004
1	Monoclonal AntibodiesIBA 12/2004
1	EpitopesIBA 12/2004

Therapy/Procedure

1	Nebulizers and Vaporizers (Inhaler) 01/2021
1	Intranasal Administration 01/2012